» Articles » PMID: 33408013

Constructing an Ethical Framework for Priority Allocation of Pandemic Vaccines

Overview
Journal Vaccine
Date 2021 Jan 7
PMID 33408013
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Allocation of scarce resources during a pandemic extends to the allocation of vaccines when they eventually become available. We describe a framework for priority vaccine allocation that employed a cross-disciplinary approach, guided by ethical considerations and informed by local risk assessment.

Methods: Published and grey literature was reviewed, and augmented by consultation with key informants, to collate past experience, existing guidelines and emerging strategies for pandemic vaccine deployment. Identified ethical issues and decision-making processes were also included. Concurrently, simulation modelling studies estimated the likely impacts of alternative vaccine allocation approaches. Assembled evidence was presented to a workshop of national experts in pandemic preparedness, vaccine strategy, implementation and ethics. All of this evidence was then used to generate a proposed ethical framework for vaccine priorities best suited to the Australian context.

Findings: Published and emerging guidance for priority pandemic vaccine distribution differed widely with respect to strategic objectives, specification of target groups, and explicit discussion of ethical considerations and decision-making processes. Flexibility in response was universally emphasised, informed by real-time assessment of the pandemic impact level, and identification of disproportionately affected groups. Model outputs aided identification of vaccine approaches most likely to achieve overarching goals in pandemics of varying transmissibility and severity. Pandemic response aims deemed most relevant for an Australian framework were: creating and maintaining trust, promoting equity, and reducing harmful outcomes.

Interpretation: Defining clear and ethically-defendable objectives for pandemic response in context aids development of flexible and adaptive decision support frameworks and facilitates clear communication and engagement activities.

Citing Articles

Racial disparities in Phase 1 COVID-19 vaccine shipments to Neighborhood sites in Pennsylvania by the Federal Retail Pharmacy Program.

Holtzman G, Yang Y, Louis P, West S, Kandaswamy P Sci Rep. 2024; 14(1):23591.

PMID: 39390039 PMC: 11466953. DOI: 10.1038/s41598-024-73116-1.


Having a real say: findings from first nations community panels on pandemic influenza vaccine distribution.

Crooks K, Taylor K, Burns K, Campbell S, Degeling C, Williams J BMC Public Health. 2023; 23(1):2377.

PMID: 38037021 PMC: 10691077. DOI: 10.1186/s12889-023-17262-7.


COVID-19 vaccination preferences during a pause in Johnson & Johnson vaccine administration.

Wagner A, Zhang F, Kerekes S, Shih S, Zhao L Vaccine X. 2023; 15:100373.

PMID: 37674932 PMC: 10477674. DOI: 10.1016/j.jvacx.2023.100373.


Priority allocation of pandemic influenza vaccines in Australia - Recommendations of 3 community juries.

Degeling C, Williams J, Carter S, Moss R, Massey P, Gilbert G Vaccine. 2020; 39(2):255-262.

PMID: 33317870 PMC: 7733601. DOI: 10.1016/j.vaccine.2020.12.010.

References
1.
Smith G, Vijaykrishna D, Bahl J, Lycett S, Worobey M, Pybus O . Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature. 2009; 459(7250):1122-5. DOI: 10.1038/nature08182. View

2.
Tillett R, Sevinsky J, Hartley P, Kerwin H, Crawford N, Gorzalski A . Genomic evidence for reinfection with SARS-CoV-2: a case study. Lancet Infect Dis. 2020; 21(1):52-58. PMC: 7550103. DOI: 10.1016/S1473-3099(20)30764-7. View

3.
Altmann D, Douek D, Boyton R . What policy makers need to know about COVID-19 protective immunity. Lancet. 2020; 395(10236):1527-1529. PMC: 7185915. DOI: 10.1016/S0140-6736(20)30985-5. View

4.
Emanuel E, Persad G, Upshur R, Thome B, Parker M, Glickman A . Fair Allocation of Scarce Medical Resources in the Time of Covid-19. N Engl J Med. 2020; 382(21):2049-2055. DOI: 10.1056/NEJMsb2005114. View

5.
Hashim A, Jean-Gilles L, Hegermann-Lindencrone M, Shaw I, Brown C, Nguyen-Van-Tam J . Did pandemic preparedness aid the response to pandemic (H1N1) 2009? A qualitative analysis in seven countries within the WHO European Region. J Infect Public Health. 2012; 5(4):286-96. DOI: 10.1016/j.jiph.2012.04.001. View